Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Literature
1.
Gupta M, Davis M, LeGrand S, Walsh D, Lagman R (2013) Nausea and vomiting in advanced cancer: the Cleveland Clinic protocol. J Support Oncol 11(1):8–13PubMed
2.
Srivastava M, Brito-Dellan N, Davis MP, Leach M, Lagman R (2003) Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer. J Pain Symptom Manag 25(6):578–582CrossRef
3.
Yang T, Liu Q, Lu M, Ma L, Zhou Y, Cui Y (2017) Efficacy of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting: a meta-analysis. Br J Clin Pharmacol 83(7):1369–1379CrossRef
4.
Harder S, Groenvold M, Isaksen J, Sigaard J, Frandsen KB, Neergaard MA, Mondrup L, Herrstedt J (2019) Antiemetic use of olanzapine in patients with advanced cancer: results from an open-label multicenter study. Support Care Cancer 27(8):2849–2856CrossRef
5.
Alkan A, Yasar A, Karci E, Koksoy EB, Urun M, Senler FC et al (2017) Severe drug interactions and potentially inappropriate medication usage in elderly cancer patients. Support Care Cancer 25(1):229–236CrossRef
Metadata
Title
Olanzapine: Sancho Panza for clinicians who care for patients with advanced cancer
Authors
Ali Alkan
Özgür Tanrıverdi
Publication date
01-04-2020
Publisher
Springer Berlin Heidelberg
Keywords
Nausea
Olanzapine
Published in
Supportive Care in Cancer / Issue 4/2020
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-05105-4

Other articles of this Issue 4/2020

Supportive Care in Cancer 4/2020 Go to the issue

Review Article

The effectiveness of mindfulness-based interventions among cancer patients and survivors: a systematic review and meta-analysis

Original Article

“All boats will rise”: Physicians’ perspectives on multidisciplinary lung cancer care in a community-based hospital setting

Review Article

The effect of exercise on aromatase inhibitor-induced musculoskeletal symptoms in breast cancer survivors :a systematic review and meta-analysis

Letter to the Editor

Prognostication, palliative care, and patient outcomes (reply to Rossi et al.)

Original Article

Prospective observational study to evaluate the persistence of treatment with denosumab in patients with bone metastases from solid tumors in routine clinical practice: final analysis

Original Article

PEG vs. sennosides for opioid-induced constipation in cancer care
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits